An important gene, BRM (Brahma homolog; also known as SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin subfamily A member 2 or SMARCA2), has been identified as a promising new target in promoting tumor suppression. The gene discussed is SMARCA2; the disease is neoplasm.